C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 7/01 (2006.01) A61K 39/00 (2006.01) A61K 39/275 (2006.01) A61K 39/295 (2006.01) C12N 15/39 (2006.01) C12N 15/62 (2006.01) C12N 15/863 (2006.01)
Patent
CA 2709925
The invention relates to modified leporipoxviruses expressing a chimeric envelope protein resulting from the fusion of an envelope protein of mature intracellular virions or of an envelope protein of enveloped extracellular virions, with an exogenous protein. These modified leporipoxviruses can be used in particular for obtaining vaccines.
L'invention est relative à des Leporipoxvirus modifiés, exprimant une protéine d'enveloppe chimérique résultant de la fusion d'une protéine d'enveloppe de virions intracellulaires matures ou d' une protéine d' enveloppe de virions extracellulaires enveloppés avec une protéine exogène. Ces Leporipoxvirus modifiés sont utilisables notamment pour l'obtention de vaccins.
Bertagnoli Stephane
Camus-Bouclainville Christelle
Gelfi Jacqueline
Pignolet Beatrice
Ecole Nationale Veterinaire Toulouse
Institut National de La Recherche Agronomique
Robic
LandOfFree
Leporipoxvirus-derived vaccine vectors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Leporipoxvirus-derived vaccine vectors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Leporipoxvirus-derived vaccine vectors will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1376675